"Page 4 - to be considered a great clinical outcome, phase 2a just needs 25% of patients to show a significant reduction in proteinuria"
There are a few quotes like this in the presentation - looks like the company is very confident with results and is looking at potential takeover offers given that they already have a timeline for partnership/takeover next steps![]()
![]()
![]()
- Forums
- ASX - By Stock
- DXB
- Ann: Investor Update
Ann: Investor Update, page-15
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
51.0¢ |
Change
0.035(7.37%) |
Mkt cap ! $280.6M |
Open | High | Low | Value | Volume |
47.5¢ | 54.0¢ | 47.5¢ | $3.360M | 6.544M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 25428 | 51.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
51.5¢ | 15478 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 25428 | 0.510 |
9 | 271116 | 0.505 |
3 | 245876 | 0.500 |
3 | 501512 | 0.495 |
4 | 56490 | 0.490 |
Price($) | Vol. | No. |
---|---|---|
0.515 | 15478 | 1 |
0.520 | 190972 | 5 |
0.525 | 188385 | 5 |
0.530 | 265966 | 8 |
0.535 | 125000 | 2 |
Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |